Laparoscopic ovarian transposition before pelvic radiation in rectal cancer patient: safety and feasibility

Annals of Surgical Innovation and Research

Alaa Abduljabbar¹  Sami Al-Asari¹ 

[1]Department of colorectal surgery, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

关键词: Rectal cancer;    Transposition;    Ovarian;    Laparoscopic;   

Others  :  791912
DOI  :  10.1186/1750-1164-6-9

 received in 2011-11-02, accepted in 2012-07-19,  发布年份 2012

【 摘 要 】

Background

Infertility due to pelvic radiation for advanced rectal cancer treatment is a major concern particularly in young patients. Pre-radiation laparoscopic ovarian transposition may offer preservation of ovarian function during the treatment however its use is limited.

Aim

The study investigates the safety, feasibility and effectiveness of pre-radiation laparoscopic ovarian transposition and its effect on ovarian function in the treatment o locally advanced rectal cancer.

Methods

Charts review of all young female patients diagnosed with locally advanced rectal cancer, underwent laparoscopic ovarian transposition, then received preoperative radiotherapy at king Faisal Specialist Hospital and Research Centre between 2003–2007.

Results

During the period studied three single patients age between 21–27 years underwent pre-radiation laparoscopic ovarian transposition for advanced rectal cancer. All required pretreatment laparoscopic diversion stoma due to rectal stricture secondary to tumor that was performed at the same time. One patient died of metastatic disease during treatment. The ovarian hormonal levels (FSH and LH) were normal in two patients. One has had normal menstrual period and other had amenorrhoea after 4 months follow-up however her ovarian hormonal level were within normal limits.

Conclusions

Laparoscopic ovarian transposition before pelvic radiation in advanced rectal cancer treatment is an effective and feasible way of preservation of ovarian function in young patients at risk of radiotherapy induced ovarian failure. However, this procedure is still under used and it is advisable to discuss and propose it to suitable patients.

【 授权许可】

   
2012 Al-Asari and Abduljabbar; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Minsky BD, Cohen AM, Enker WE: Preoperative 5-FU, low dose leucovorin, and concurrent radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 15 January 1997, 37(2):289-295.
• [2]Bosset JF, Pavy JJ, Hamers HP: Determination of the optimal dose of 5-fluorouracil when combined with low dose D. L-leucovorin and irradiation in rectal cancer. Results of three consecutive phase II studies. Eur J Cancer 1993, 29:476.
• [3]Farber LA, Ames JW, Rush S, Gal D: Laparoscopic Ovarian Transposition to Preserve Ovarian Function Before Pelvic Radiation and Chemotherapy in a Young Patient With Rectal Cancer. MedGenMed 2005, 7(1):66.
• [4]Wallace WH, Shalet SM, Tetlow LJ, Morris-Jones PH: Ovarian function following the treatment of childhood acute lymphoplastic leukaemia. Med Pad. Oncol. 1993, 21:33-339.
• [5]Morice P, Thiam-Ba R, Castaine D: Fertility results after ovarian transposition for pelvic malignancies treated by external irradiation or brachytherapy. Hum Reprod 1998, 13:660-663.
• [6]Dabirashrafi H, Moghadami-Tabrizi N, Zandinejad K: Laparoscopic ovarian transposition with subsequent intrauterine pregnancy. J Am Assoc Gynecol Laparosc 1996, 3:515-517.
• [7]Hodel K, Rich WM, Austin P: The role of ovarian transposition in conservation of ovarian function in radical hysterectomy followed by pelvic radiation. Gynecol Oncol 1982, 13:195.
• [8]Husseinzadeh N, Nahhas WA, Velkley DE: The preservation of ovarian function in young women undergoing pelvic radiation therapy. Gynecol Oncol 1984, 18:373.
• [9]Chambers SK, Chambers JT, Holm C: Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients. Gynecol Oncol 1990, 39:155.
• [10]Chambers SK, Chambers JT, Kier R: Sequelae of lateral ovarian transposition in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys 1991, 20:1305.
• [11]Feeney DD, Moore DH, Look KY: The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol 1995, 56:3.
• [12]Covens AL, van der Putten HW, Fyles AW: Laparoscopic ovarian transposition. Eur J Gynaecol Oncol 1996, 17:177.
• [13]Van Eijkeren MA, Van DWI, El Sharouni SY: Benefits and side effects of lateral ovarian transposition performed during radical hysterectomy and pelvic lymphadenectomy for early stage cervical cancer. Int J Gynecol Cancer 1999, 9:396.
• [14]Morice P, Juncker L, Rey A: Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril 2000, 74:743.
• [15]Yamamoto R, Okamoto K, Yukiharu T: A study of risk factors for ovarian metastases in stage IB-IIIB cervical carcinoma and analysis of ovarian function after a transposition. Gynecol Oncol 2001, 82:312.
• [16]Buekers TE, Anderson B, Sorosky JI: Ovarian function after surgical treatment for cervical cancer. Gynecol Oncol 2001, 80:85.
• [17]Treissman MJ, Miller D, McComb PF: Laparoscopic lateral ovarian transposition. Fertil Steril 1996, 65:1229-1231.